Meglitinides

C 745 Pill - yellow round

Pill with imprint C 745 is Yellow, Round and has been identified as Repaglinide 1 mg. It is supplied by Sun Pharmaceutical Industries Inc.

Repaglinide is used in the treatment of Diabetes, Type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 1 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Repaglinide (Repaglinide (oral) [ re-pag-li-nide ])-C 745-1 mg-Yellow-Round
Repaglinide (Repaglinide (oral) [ re-pag-li-nide ])-C 745-1 mg-Yellow-Round
Repaglinide (Repaglinide (oral) [ re-pag-li-nide ])-C 745-1 mg-Yellow-Round
Repaglinide (Repaglinide (oral) [ re-pag-li-nide ])-C 745-1 mg-Yellow-Round
Repaglinide (Repaglinide (oral) [ re-pag-li-nide ])-C 745-1 mg-Yellow-Round

Repaglinide
Generic Name: repaglinide (oral) [ re-pag-li-nide ]
Imprint: C 745
Strength: 1 mg
Color: Yellow
Size: N/A
Shape: Round
Availability: Prescription only
Drug Class: Meglitinides
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Calcium phosphate dibasic anhydrous, Microcrystalline cellulose, Corn starch, Meglumine, Croscarmellose sodium, Magnesium stearate, Silicon dioxide, Ferric oxide yellow,
Latest News
Related Drugs